1. 成都中医药大学附属医院内分泌科
2. 四川大学华西医院
3. 广西中医学院第一附属医院
纸质出版:2012
移动端阅览
[1]李朝敏,龚枚,李明权,夏庆,陈远平.当飞利肝宁胶囊治疗非酒精性单纯性脂肪肝患者113例临床研究[J].中医杂志,2012,53(01):38-41.
LI Chaomin 1, GONG Mei 1, LI Mingquan 1, et al. Clinical Study on Dangfei Liganning Capsule for Nonalcoholic Simple Fatty Liver Disease:a Report on 113 Cases[J]. Journal of Traditional Chinese Medicine2012, 53(1): 38-41.
[1]李朝敏,龚枚,李明权,夏庆,陈远平.当飞利肝宁胶囊治疗非酒精性单纯性脂肪肝患者113例临床研究[J].中医杂志,2012,53(01):38-41. DOI: 10.13288/j.11-2166/r.2012.01.024.
LI Chaomin 1, GONG Mei 1, LI Mingquan 1, et al. Clinical Study on Dangfei Liganning Capsule for Nonalcoholic Simple Fatty Liver Disease:a Report on 113 Cases[J]. Journal of Traditional Chinese Medicine2012, 53(1): 38-41. DOI: 10.13288/j.11-2166/r.2012.01.024.
目的评价当飞利肝宁胶囊治疗湿热内蕴型非酒精性单纯性脂肪肝的有效性和安全性。方法选择非酒精性单纯性脂肪肝湿热内蕴证患者230例
符合全分析集(full analysis set
FAS)患者227例
其中当飞利肝宁胶囊组(试验组)113例
安慰剂组(对照组)114例
疗程均为12周
以治疗后肝/脾CT比值变化、肝/脾CT比值复常率以及中医证候评价有效性
以不良反应、实验室检查及心电图评价安全性。结果两组治疗后肝/脾CT值较治疗前差异有统计学意义(P<0.01)
两组治疗后比较差异有统计学意义(P<0.01)。试验组肝/脾CT比值复常率为47.79%(54/113)
优于对照组的22.81%(26/114)
组间比较差异具有统计学意义(P<0.01)。试验组总有效率为76.11%
对照组为55.26%
两组比较差异有统计学意义(P<0.01)。两组治疗后脘腹痞闷、口干口苦评分较治疗前降低(P<0.01);并且试验组治疗后明显低于对照组(P<0.01)。试验组治疗后丙氨酸氨基转移酶(ALT)较治疗前降低(P<0.01)
对照组ALT较治疗前也有降低但差异无统计学意义(P>0.05)
治疗后两组患者其他肝功能及血脂指标较治疗前比较差异均无统计学意义(P>0.05)。结论当飞利肝宁胶囊对非酒精性单纯性脂肪肝湿热内蕴证患者有较好的治疗作用
临床应用安全。
Objective To evaluate the effect and safety of Dangfei Liganning Capsule [ Capsule of Dangyao (Swertia sinensis) and Shuifeiji (Silybum marianum) for the liver diseases ] in the treatment of nonalcoholic simple fatty liver disease with the damp-heat retention syndrome in TCM.Methods A multicentric
randomized
double-blind
placebo parallel controlled trial was conducted in the treatment of nonalcoholic simple fatty liver disease.Totally 230patients accorded with the standards of diagnosis of nonalcoholic simple fatty liver disease and damp-heat retention syndrome in TCM were in cluded
of which
227were of full analysis set (FAS)
and were randomized into Dangfei Liganning Capsule group (trial
113cases) and placebo group (control
114cases).The course of treatment was of 12weeks.The effect was evaluated with the changes in the liver/spleen CT ratio
liver/spleen CT recovery ratio
and improvement of TCM symptoms
while the safety was assessed with the adverse events
laboratory examination
and changes in ECG.Results After treatment
the liver/ spleen CT ratio of both groups was significantly different from that before treatment (P<0.01)
and the difference between the two groups was statistically significant (P<0.01).In the trial group
the liver/ spleen CT recovery rate was 47.79% (54/ 113cases)
while that of controlled group was 22.81% (26/ 114cases).The difference between groups was statistically significant (P<0.01).The total effective rate of the trial group and the control group was 76.11%and 55.26%respectively
the difference was significant (P<0.01).The epigastric distention and fullness and dry mouth and bitter taste of both groups after treatment were significantly alleviated
being significantly different from those of before treatment (P<0.01).The difference in the between-group comparison after treatment was statistically significant (P<0.01)
the trial group was superior to the control group.The ALT decrease of the trial group after treatment was statistically significant (P<0.01)
the ALT decrease of the control group was not statistically significant (P>0.05)
and the difference between groups was not statistically significant (P>0.05).Conclusion Dangfei Liganning Capsule is effective and safe in the treatment of nonalcoholic simple fatty liver disease with the damp-heat retention syndrome in TCM.
0
浏览量
438
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号